Papers/PMID:19228872
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.
Diabetes care2009The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
coenzyme Q10 — increases flow-mediated dilation
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Findingreplicated ×1“CoQ10 increased brachial artery FMD by mean ± SEM 1.0 ± 0.5% (P = 0.04) compared with placebo but did not alter nitrate-mediated dilatation (P = 0.66).”
Quoted verbatim from Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.. - Study
- crossover
- Duration
- 3 months
- Dose
- 200 mg/day
- Population
- Statin-treated type 2 diabetic patients aged 40-79 years with endothelial dysfunction (brachial FMD <5.5%) and LDL cholesterol <2.5 mmol/l; double-blind crossover versus placebo
Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients.2009PMID:19228872Permalink